# Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer

> **NCT01164202** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 78 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** sunitinib malate
- **DRUG:** Placebo
- **PROCEDURE:** transarterial chemoembolization

## Key facts

- **NCT ID:** NCT01164202
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164202, "Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01164202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*